International Comparisons of Stroke Costs Are Always Limited | Zendy

Erik Lundström | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

International Comparisons of Stroke Costs Are Always Limited

Author(s) -

Erik Lundström

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.584367

Subject(s) - medicine , spasticity , tizanidine , stroke (engine) , dantrolene , botulinum toxin , rehabilitation , neurology , health care , physical therapy , psychiatry , surgery , mechanical engineering , engineering , calcium , economic growth , economics

To the Editor:The Editorial comment by Low et al1 highlights 2 important issues with regard to treatment and costs for spasticity.2First, 20% of patients with spasticity were prescribed benzodiazepines for various indications; no patient received baclofen, dantrolene, or tizanidine; and no patient had been treated by botulinum toxin. This finding was unexpected and might reflect reluctance to use oral drugs with a less favorable effect or side effect ratio in patients with …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research